| Answer | Low risk | LA19542-2 |
| Answer | High risk | LA19541-4 |
| Answer | Risk unchanged | LA21393-6 |
| Answer | Test not performed | LA13546-9 |
| answers-for | Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75552-0 |
| answers-for | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75558-7 |
| answers-for | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75564-5 |
| answers-for | Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75570-2 |
| answers-for | Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75572-8 |
| answers-for | Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75578-5 |
| answers-for | Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75584-3 |
| answers-for | Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75590-0 |
| answers-for | Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75596-7 |
| answers-for | Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | 75602-3 |
| answers-for | Trisomy 13, trisomy 18 or triploidy risk [Interpretation] in Plasma cell-free+WBC DNA Qualitative by calculation | 96979-0 |
| LONG_COMMON_NAME | en-US | NIPS Panorama |
LOINC Version: 2.77
FHIR